Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Therapy01:28

Drug Therapy

69
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
69
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

199
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
199
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
Pharmacovigilance01:19

Pharmacovigilance

891
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
891

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predictive accuracy of gait speed for falls: An individual participant data meta-analysis.

Ageing research reviews·2026
Same author

Industry Payments to Physicians Alter the Care of Patients With Multiple Sclerosis: It's Time to Cut Financial Ties.

Neurology·2026
Same author

Peer-assisted telemedicine for hepatitis C intervention in people experiencing housing instability.

Harm reduction journal·2026
Same author

Stop the Spin: Confronting Reporting Bias in Multiple Sclerosis Research.

Annals of neurology·2026
Same author

Late-Onset Multiple Sclerosis: Is Disease-Modifying Therapy Indicated?

Neurology·2025
Same author

Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program.

Neurology. Clinical practice·2025

相关实验视频

Updated: Jul 20, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

多发性硬化症中的多药学:患病率,风险和缓解策略

W Daniel Chapman1, Megan C Herink2, Michelle H Cameron3

  • 1Department of Neurology, Oregon Health & Science University, Portland, OR, USA. wdanielchapman@gmail.com.

Current neurology and neuroscience reports
|July 31, 2023
PubMed
概括

多药,使用5种以上的药物,在多发性硬化症 (MS) 中很常见,并且与糟糕的结果有关. 医疗保健提供者应评估药物的适当性和风险,以减轻MS患者的危害.

关键词:
抗胆固醇负担 抗胆固醇负担删除描述的内容多发性硬化症是多发性硬化症.多种药房 多种药房症状性治疗 症状性治疗

更多相关视频

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

相关实验视频

Last Updated: Jul 20, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

科学领域:

  • 神经学 神经学
  • 药理学 药理学是指药理学的学科.
  • 患者安全 患者安全

背景情况:

  • 多种药物 (≥5种药物) 在多发性硬化症 (MS) 患者中很普遍.
  • 多种药物用于MS症状管理,增加风险.
  • 这些风险包括药物相互作用和添加副作用.

研究的目的:

  • 审查多药在多发性硬化症的患病率和风险.
  • 为识别和减轻不适当的多药药提供策略.
  • 为医疗保健提供者提供指导,以优化MS患者的药物治疗.

主要方法:

  • 在多发性硬化症中的多药学研究的文献综述.
  • 对药物类别对不适当的多药学的贡献进行分析.
  • 识别与多药性相关的风险因素和负面结果在MS.

主要成果:

  • 多药性是常见的,并且与多发性硬化症的负面结果有关.
  • 特定的药物类别有助于潜在的不适当的多药.
  • 多发性硬化症患者面临着与多药相关问题的显著风险.

结论:

  • 多发性硬化症提供者必须评估药物治疗的适当性和风险.
  • 应该考虑在个体患者需求的背景下停止处方.
  • 缓解多药性治疗对于改善多发性硬化症患者的治疗结果至关重要.